We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Stock Market Roundup Dec. 7: Stocks Gain Despite Biotech Sell-Off
Read MoreHide Full Article
The major indexes were up across the board on Wednesday, despite a massive sell-off in the biotechnology sector initiated by a new promise from President-elect Trump that he will be targeting drug price hikes. Japan’s SoftBank (SFTBY - Free Report) and Sprint (S - Free Report) were also up on some Trump-based news, while iPhone maker Apple (AAPL - Free Report) ) reported some good news.
Apple’s SVP of Internet Software and Products Eddy Cue told Billboard that the company’s highly successful music streaming platform Apple Music has hit 20 million paying subscribers.
Shares of the iShares Nasdaq Biotechnology ETF (IBB - Free Report) were down more than 3.6% in morning trading Wednesday following a new warning from President-elect Donald Trump that he will indeed be targeting high drug prices.
Shares of Japanese telecom giant SoftBank gained more than 5% in morning trading Wednesday after CEO Masayoshi Son promised to invest $50 billion in the United States and create 50,000 new jobs. Shares of Sprint, which is 82%-owned by SoftBank, were also up big by midday.
Stocks that Aren't in the News. Yet.
You are invited to download the full, up-to-the-minute list of 220 Zacks Rank #1 "Strong Buys" free of charge. Many of these companies are almost unheard of by the general public and just starting to get noticed by Wall Street. They have been pinpointed by the Zacks system that nearly tripled the market from 1988 through 2015 with a stellar average gain of +26% per year. See these high-potential stocks free >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Stock Market Roundup Dec. 7: Stocks Gain Despite Biotech Sell-Off
The major indexes were up across the board on Wednesday, despite a massive sell-off in the biotechnology sector initiated by a new promise from President-elect Trump that he will be targeting drug price hikes. Japan’s SoftBank (SFTBY - Free Report) and Sprint (S - Free Report) were also up on some Trump-based news, while iPhone maker Apple (AAPL - Free Report) ) reported some good news.
Zacks Rank #1 (Strong Buy) Biggest Movers
Value: Valeo SA (VLEEY - Free Report) +4.95%
Growth: Bob Evans Farms +6.97%
Momentum: BOBE
VGM: BOBE
Income: Western Digital Corp. (WDC - Free Report) +7.92%
Major Indexes
DOW: 19,549.62 / 297.84 / 1.55%
NASDAQ: 5,393.76 / 60.76 / 1.14%
S&P 500: 2,241.35 / 29.12 / 1.32%
Top Headlines
Apple Music Achieves 20 Million Paying Subscribers
Apple’s SVP of Internet Software and Products Eddy Cue told Billboard that the company’s highly successful music streaming platform Apple Music has hit 20 million paying subscribers.
Trump Vows to Slash Drug Prices, Sends Biotech Stocks Lower
Shares of the iShares Nasdaq Biotechnology ETF (IBB - Free Report) were down more than 3.6% in morning trading Wednesday following a new warning from President-elect Donald Trump that he will indeed be targeting high drug prices.
SoftBank and Sprint Soaring on Trump-backed Investment Plan
Shares of Japanese telecom giant SoftBank gained more than 5% in morning trading Wednesday after CEO Masayoshi Son promised to invest $50 billion in the United States and create 50,000 new jobs. Shares of Sprint, which is 82%-owned by SoftBank, were also up big by midday.
Stocks that Aren't in the News. Yet.
You are invited to download the full, up-to-the-minute list of 220 Zacks Rank #1 "Strong Buys" free of charge. Many of these companies are almost unheard of by the general public and just starting to get noticed by Wall Street. They have been pinpointed by the Zacks system that nearly tripled the market from 1988 through 2015 with a stellar average gain of +26% per year. See these high-potential stocks free >>